Citation Impact
Citing Papers
Parthenolide promotes the ubiquitination of MDM2 and activates p53 cellular functions
2009
Distinct fibroblast lineages determine dermal architecture in skin development and repair
2013 StandoutNature
Identification of Distinct Basal and Luminal Subtypes of Muscle-Invasive Bladder Cancer with Different Sensitivities to Frontline Chemotherapy
2014 Standout
Phosphorylation at Ser473 regulates heterochromatin protein 1 binding and corepressor function of TIF1beta/KAP1
2008
Mitochondria and Epigenetics – Crosstalk in Homeostasis and Stress
2017
Histone deacetylases (HDACs) as therapeutic target for depressive disorders
2017
Complete Genetic Correction of iPS Cells From Duchenne Muscular Dystrophy
2009 StandoutNobel
The DNA-damage response in human biology and disease
2009 StandoutNature
TRIM proteins and cancer
2011
Writers and Readers of Histone Acetylation: Structure, Mechanism, and Inhibition
2014
The molecular hallmarks of epigenetic control
2016 Standout
Vaccine delivery: a matter of size, geometry, kinetics and molecular patterns
2010 Standout
Transcriptional Silencing by Polycomb-Group Proteins
2014
AMPK: guardian of metabolism and mitochondrial homeostasis
2017 Standout
Myositis autoantibodies
2012
T cell exhaustion
2011 Standout
Epigallocatechin-3-gallate inhibits cell cycle and induces apoptosis in pancreatic cancer
2007
Role of Oncogenes and Tumor-suppressor Genes in Carcinogenesis: A Review
2020 Standout
Targeting Ferroptosis to Iron Out Cancer
2019 Standout
TGFβ signalling in context
2012 Standout
Role of AID in Tumorigenesis
2007 StandoutNobel
Chromatin‐modifying proteins in cancer
2007
Chromatin relaxation in response to DNA double-strand breaks is modulated by a novel ATM- and KAP-1 dependent pathway
2006
Structure and function of long noncoding RNAs in epigenetic regulation
2013 Standout
Rethinking mechanisms, diagnosis and management of endometriosis
2019 Standout
Long Noncoding RNAs in Cancer Pathways
2016 Standout
Degradation of AMPK by a Cancer-Specific Ubiquitin Ligase
2015
A Structural Perspective on Readout of Epigenetic Histone and DNA Methylation Marks
2016
New insights into the mechanisms of epithelial–mesenchymal transition and implications for cancer
2018 Standout
Integrative genomic analysis reveals widespread enhancer regulation by p53 in response to DNA damage
2015
Inactivation of a Human Kinetochore by Specific Targeting of Chromatin Modifiers
2008
Epigenetic Regulation of Chromatin States inSchizosaccharomyces pombe
2015
What made sesquiterpene lactones reach cancer clinical trials?
2010 Standout
Transcriptional activation of caspase-6 and -7 genes by cisplatin-induced p53 and its functional significance in cisplatin nephrotoxicity
2007
Excess HDM2 Impacts Cell Cycle and Apoptosis and Has a Selective Effect on p53-dependent Transcription
2006
Blinded by the Light: The Growing Complexity of p53
2009 Standout
Reactive oxygen species (ROS) as pleiotropic physiological signalling agents
2020 Standout
Anchor extension: a structure-guided approach to design cyclic peptides targeting enzyme active sites
2021 StandoutNobel
Regulation and Pathological Role of p53 in Cisplatin Nephrotoxicity
2008
Silibinin activates p53-caspase 2 pathway and causes caspase-mediated cleavage of Cip1/p21 in apoptosis induction in bladder transitional-cell papilloma RT4 cells: evidence for a regulatory loop between p53 and caspase 2
2006
The c‐myc Promoter: Still MysterY and Challenge
2007
A library of gene expression signatures to illuminate normal and pathological lymphoid biology
2006
The Role of Short-Chain Fatty Acids From Gut Microbiota in Gut-Brain Communication
2020 Standout
Mechanism of p53 stabilization by ATM after DNA damage
2010
Epigenetic Regulation in Plants
2014
Intrinsically disordered proteins in cellular signalling and regulation
2014 Standout
p53 mediates the negative regulation of MDM2 by orphan receptor TR3
2006
Programmed Cell Senescence during Mammalian Embryonic Development
2013 Standout
PROTAC targeted protein degraders: the past is prologue
2022 Standout
Reflecting on 25 years with MYC
2008 Standout
Histone Modifications and Cancer
2016
Structural and Functional Coordination of DNA and Histone Methylation
2014
Reactive oxygen species in cancer
2010 Standout
Metabolic Signaling to Chromatin
2015
Green tea catechin, epigallocatechin-3-gallate (EGCG): Mechanisms, perspectives and clinical applications
2011 Standout
Multitargeted therapy of cancer by silymarin
2008 Standout
Defining roles of specific reactive oxygen species (ROS) in cell biology and physiology
2022 Standout
Delineating Crosstalk Mechanisms of the Ubiquitin Proteasome System That Regulate Apoptosis
2018
Oxidative stress-mediated alterations in histone post-translational modifications
2021
TRIM28 prevents autoinflammatory T cell development in vivo
2012 StandoutNobel
PRDI-BF1 recruits the histone H3 methyltransferase G9a in transcriptional silencing
2004
Defining trained immunity and its role in health and disease
2020 Standout
Cyclometalated Ir(iii ) complexes as targeted theranostic anticancer therapeutics: combining HDAC inhibition with photodynamic therapy
2014
Epigenetic Determinants of Cancer
2016
Hepatitis B virus induces RNR-R2 expression via DNA damage response activation
2015 StandoutNobel
ROS and the DNA damage response in cancer
2018 Standout
Cystine transporter SLC7A11/xCT in cancer: ferroptosis, nutrient dependency, and cancer therapy
2020 Standout
The first 30 years of p53: growing ever more complex
2009 Standout
Smad3‐mediated recruitment of the methyltransferase SETDB1/ESET controls Snail1 expression and epithelial–mesenchymal transition
2017
Blimp1 regulates development of the posterior forelimb, caudal pharyngeal arches, heart and sensory vibrissae in mice
2007
SOCS1 regulates senescence and ferroptosis by modulating the expression of p53 target genes
2017
Cytotoxicity of 11-epi-Sinulariolide Acetate Isolated from Cultured Soft Corals on HA22T Cells through the Endoplasmic Reticulum Stress Pathway and Mitochondrial Dysfunction
2016
Inflammatory Muscle Diseases
2015 Standout
MCPH1/BRIT1 cooperates with E2F1 in the activation of checkpoint, DNA repair and apoptosis
2008
Inactivation of the PRDM1/BLIMP1 gene in diffuse large B cell lymphoma
2006
Follicular Helper CD4 T Cells (TFH)
2011 Standout
Mechanisms of Cisplatin Nephrotoxicity
2010 Standout
Measuring Histone Deacetylase Inhibition in the Brain
2018
The development of anticancer ruthenium(ii ) complexes: from single molecule compounds to nanomaterials
2017 Standout
DNA methylation in the central and efferent limbs of the chemoreflex requires carotid body neural activity
2017 StandoutNobel
Histone H3 lysine 9 di-methylation as an epigenetic signature of the interferon response
2012 StandoutNobel
Natural and Designed Proteins Inspired by Extremotolerant Organisms Can Form Condensates and Attenuate Apoptosis in Human Cells
2022 StandoutNobel
Current and emerging treatment options for endometriosis
2018
Epigenetics in Saccharomyces cerevisiae
2013
Marine natural products
2018 Standout
ATM and ATR Substrate Analysis Reveals Extensive Protein Networks Responsive to DNA Damage
2007 StandoutScience
Regulation and Functions of Blimp-1 in T and B Lymphocytes
2008
Molecular signatures database (MSigDB) 3.0
2011 Standout
HDACs and HDAC Inhibitors in Cancer Development and Therapy
2016
The Controversial Role of Human Gut Lachnospiraceae
2020 Standout
Bromodomain and Extra-Terminal Motif Inhibitors: a Review of Preclinical and Clinical Advances in Cancer Therapy
2019
Promotion of direct reprogramming by transformation-deficient Myc
2010 StandoutNobel
Differentiation of Effector CD4 T Cell Populations
2010 Standout
Methylation-Acetylation Interplay Activates p53 in Response to DNA Damage
2007
Works of Ed Seto being referenced
Erasers of Histone Acetylation: The Histone Deacetylase Enzymes
2014
MDM2 interaction with nuclear corepressor KAP1 contributes to p53 inactivation
2005
Differential regulation of human YY1 and caspase 7 promoters by prohibitin through E2F1 and p53 binding sites
2006
Identification of a Functionally Impaired Positive Regulatory Domain I Binding Factor 1 Transcription Repressor in Myeloma Cell Lines
2003